Geneoscopy is committed to leveraging its platform technology to assess RNA biomarkers non-invasively in stool to advance research and clinical management of gastrointestinal disease, initially in colorectal cancer. These studies are taking place in collaboration with academic and institutional leaders in the field and will allow us to offer new ways for clinicians to help prevent and diagnose disease, monitor patient health, and improve health outcomes.